This encouraging data, along with the pro-coagulant nature and phagocyte recruitment capabilities of IL-1β, prompted the Canakinumab Anti-inflammatory Thrombosis Outcome Study (CANTOS) to determine the role of IL-1β-induced inflammation in atherosclerosis (Aday and Ridker, 2018). Here, IL1B is linked to atherosclerosis.